# US 2024/0200070 A1 · Expanding the chemical substrates for genetic code reprogramming

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0200070 A1
- Document ID: US20240200070A1
- Status: Published application
- Kind: A1
- Application number: 18/469,530
- Filed: 2023-09-18
- Published: 2024-06-20
- Earliest claimed: 2018-06-01
- Assignees: Northwestern University; The Board of Trustees of the University of Illinois
- Applicants: Northwestern University; The Board of Trustees of the University of Illinois
- Inventors: Michael Christopher Jewett; Joongoo Lee; Jeffrey S. Moore; Kenneth E. Schwieter; Kevin Jerome Schwarz
- Web page: https://patentgrep.com/patent/US20240200070A1

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12N 2310/351: Conjugate
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

Disclosed are methods, systems, components, and compositions for synthesis of sequence defined polymers. The methods, systems, components, and compositions may be utilized for incorporating novel substrates that include non-standard amino acid monomers and non-amino acid monomers into sequence defined polymers. As disclosed herein, the novel substrates may be utilized for acylation of tRNA via flexizyme catalyzed reactions. The tRNAs thus acylated with the novel substrates may be utilized in synthesis platforms for incorporating the novel substrates into a sequence defined polymer.

## Claims

### Claim 1

A donor molecule having a formula defined as:
wherein:
LG is a leaving group:
X is O or S; and
R is selected from the group consisting of alkyl; cycloalkyl optionally substituted with amino; heterocycloalkyl; alkylheterocycloalkyl; alkenyl; cyanoalkyl; aminoalkyl; aminoalkenyl; alkylcarboxyalkylester; haloalkyl; nitroalkyl; aryl, (aryl)alkyl, and (aryl)alkenyl, wherein the aryl or the aryl of the (aryl)alkyl or (aryl)alkenyl is optionally substituted with one or more substituents selected from hydroxyl, hydroxylalkyl, amino, aminoalkyl, azido, cyano, acetyl, nitro, nitroalkyl, halo, alkoxy, and alkynyl.

### Claim 2 (depends on 1)

The molecule of claim 1, wherein R is substituted alkylaryl.

### Claim 3 (depends on 1)

The molecule of claim 1, wherein R is substituted phenyl.

### Claim 4 (depends on 1)

The molecule of claim 1, wherein R is heteroaryl or substituted heteroaryl.

### Claim 5 (depends on 1)

The molecule of claim 1, wherein R comprises a primary amine group or a secondary amine group in a gamma position, a delta position, an epsilon position, or a zeta position.

### Claim 6 (depends on 1)

The molecule of claim 1, wherein R comprises a cycloalkyl group optionally substituted with amino.

### Claim 7 (depends on 1)

The molecule of claim 1, wherein R comprises a cyclic secondary amine.

### Claim 8 (depends on 1)

The molecule of claim 1, wherein R is selected from alkyl, alkenyl, cyanoalkyl, and alkylcarboxylalkyl ester.

### Claim 9

A method for preparing a sequence defined polymer, wherein the sequence defined polymer is prepared via translating an mRNA comprising a codon corresponding to an anticodon of an acylated tRNA molecule and the R group of the acylated tRNA molecule is incorporated in the sequence defined polymer during translation of the mRNA,
wherein the acylated tRNA molecule has a formula defined as:
wherein:
tRNA is a transfer RNA linked via a 3′ terminal ribonucleotide; and
R is selected from alkyl; cycloalkyl optionally substituted with amino; heterocycloalkyl;
and alkylheterocycloalkyl; alkenyl; cyanoalkyl; aminoalkyl; aminoalkenyl;
alkylcarboxyalkylester; haloalkyl; nitroalkyl; aryl, (aryl)alkyl, or (aryl)alkenyl, wherein the aryl or the aryl of the (aryl)alkyl or (aryl)alkenyl is optionally substituted with one or more substituents selected from hydroxyl, hydroxylalkyl, amino, aminoalkyl, azido, cyano, acetyl, nitro, nitroalkyl, halo, alkoxy, and alkynyl.

### Claim 10 (depends on 9)

The method of claim 9, wherein the method is performed in vitro.

### Claim 11 (depends on 9)

The method of claim 9, wherein the method is performed in vivo.

### Claim 12 (depends on 9)

The method of claim 9, wherein the codon is the start codon (AUG) of the mRNA.

### Claim 13 (depends on 9)

The method of claim 9, wherein the codon is selected from a codon for threonine, a codon for isoleucine, and a codon for alanine.

### Claim 14 (depends on 9)

The method of claim 9, wherein the sequence defined polymer is a polymer selected from polyolefin polymers, aramid polymers, polyurethane polymers, polyketide polymers, conjugated polymers, D-amino acid polymers, β-amino acid polymers, γ-amino acid polymers, δ-amino acid polymers, ε-amino acid polymers, ζ-amino acid polymers, and polycarbonate polymers.

### Claim 15 (depends on 1)

A method for preparing an acylated tRNA molecule having a formula defined as:
wherein
tRNA is a transfer RNA linked via a 3′ terminal ribonucleotide; and
the method comprising reacting in a reaction mixture:
(i) a flexizyme (Fx):
(ii) the tRNA molecule; and
(iii) the donor molecule according to claim 1
wherein
the Fx catalyzes an acylation reaction between the 3′ terminal ribonucleotide of the tRNA and the donor molecule to prepare the acylated tRNA molecule.

### Claim 16 (depends on 15)

The method of claim 15, wherein the Fx is selected from aFx, dFx, and eFx.

### Claim 17 (depends on 15)

The method of claim 15, wherein the tRNA comprises an anticodon selected from the anticodon CAU), the anticodon GGU, the anticodon GAU, or the anticodon GGC.

### Claim 18 (depends on 15)

The method of claim 15, wherein LG comprises a cyanomethyl moiety and the donor molecule comprises a cyanomethylester (CME).

### Claim 19 (depends on 15)

The method of claim 15, wherein LG comprises a dinitrobenzyl moiety and the donor molecule comprises a dinitrobenzylester (DNB).

### Claim 20 (depends on 15)

The method of claim 15, wherein LG comprises a (2-aminoethyle)amidocarboxybenzyl moiety and the donor molecule comprises a (2-aminoethyl)amidocarboxybenzyl thioester (ABT).

### Claim 21 (depends on 15)

The method of claim 15, wherein the method is performed under reaction conditions such that at least about 50% of the tRNA in the reaction mixture is acylated after reacting the reaction mixture for 120 hours, and preferably at least about 50% of the tRNA in the reaction mixture is acylated after reacting the reaction mixture for 16 hours.

### Claim 22 (depends on 1)

The molecule of claim 1, wherein LG comprises a cyanomethyl moiety and the donor molecule comprises a cyanomethylester (CME).

### Claim 23 (depends on 1)

The molecule of claim 1, wherein LG comprises a dinitrobenzyl moiety and the donor molecule comprises a dinitrobenzylester (DNB).

### Claim 24 (depends on 1)

The molecule of claim 1, wherein LG comprises a (2-aminoethyle)amidocarboxybenzyl moiety and the donor molecule comprises a (2-aminoethyl)amidocarboxybenzyl thioester (ABT).

### Claim 25 (depends on 1)

The molecule of claim 1, wherein R is selected from the group consisting of 3,4-dihydroxyphenyl-methyl, pyrrol-2-yl-methyl, and 4-amino-phenyl-methyl, 4-nitrophenyl, 4-cyanophenyl, 4-azidophenyl, 3-acetylphenyl, 4-nitromethyphenyl, 2-fluorophenyl, 4-methoxyphenyl, 3-hydroxy-4-nitrophenyl, 3-amino-4-nitrophenyl, and 3-nitro-4-aminophenyl, pyridinyl, fluoropyridinyl, coumarinyl, pyrrolyl, thiophen-2-yl, and 5-aminomethyl-furan-3-yl, 3-aminopropyl, 4-aminobutyl, 5-aminobutyl, 1,1-dimethyl-3-aminopropanyl, 3-methylamino-propanyl, 3-aminohexyl, 3-amino-1-propenyl, cyclobutyl, 2-aminocyclobutyl, cyclopentyl, 2-aminocyclopentyl, cyclohexyl, 2-aminocyclohexyl, piperidin-4-yl, (piperidin-4-yl)methyl, piperazin-4-yl, and (piperazin-4-yl)methyl.

### Claim 26

An acylated tRNA molecule having a formula defined as:
wherein:
tRNA is a transfer RNA linked via a 3′ terminal ribonucleotide; R is selected from the group consisting of alkyl; cycloalkyl optionally substituted with amino; heterocycloalkyl; alkylheterocycloalkyl; alkenyl; cyanoalkyl; aminoalkyl; aminoalkenyl; alkylcarboxyalkylester; haloalkyl; nitroalkyl; aryl, (aryl)alkyl, and (aryl)alkenyl, wherein the aryl or the aryl of the (aryl)alkyl or (aryl)alkenyl is optionally substituted with one or more substituents selected from hydroxyl, hydroxylalkyl, amino, aminoalkyl, azido, cyano, acetyl, nitro, nitroalkyl, halo, alkoxy, and alkynyl.

### Claim 27 (depends on 26)

The molecule of claim 26, wherein R has a primary amine group or a secondary amine group in a gamma position, a delta position, an epsilon position, or a zeta position.

### Claim 28 (depends on 26)

The molecule of claim 26, wherein R has a primary amine group or a secondary amine group in an epsilon position or a zeta position.

### Claim 29 (depends on 26)

The molecule of claim 26, wherein R is selected from the group consisting of 3,4-dihydroxyphenyl-methyl, pyrrol-2-yl-methyl, and 4-amino-phenyl-methyl, 4-nitrophenyl, 4-cyanophenyl, 4-azidophenyl, 3-acetylphenyl, 4-nitromethyphenyl, 2-fluorophenyl, 4-methoxyphenyl, 3-hydroxy-4-nitrophenyl, 3-amino-4-nitrophenyl, and 3-nitro-4-aminophenyl, pyridinyl, fluoropyridinyl, coumarinyl, pyrrolyl, thiophen-2-yl, and 5-aminomethyl-furan-3-yl, 3-aminopropyl, 4-aminobutyl, 5-aminobutyl, 1,1-dimethyl-3-aminopropanyl, 3-methylamino-propanyl, 3-aminohexyl, 3-amino-1-propenyl, cyclobutyl, 2-aminocyclobutyl, cyclopentyl, 2-aminocyclopentyl, cyclohexyl, 2-aminocyclohexyl, piperidin-4-yl, (piperidin-4-yl)methyl, piperazin-4-yl, and (piperazin-4-yl)methyl.
